Change Healthcare Cyberattack – continuing coverage
Here is the latest update from UnitedHealth Group. We encourage you to bookmark and check the UHG site regularly for updates.
March 2024 Annals highlights
This month’s articles and reviews provide guidance for these changes in our treatment pathways.
AllergyTalk podcast features OUtMATCH study
The FDA announced its approval of omalizumab as the first biologic medication to treat patients with food allergy.
It takes a village
What does it take to bring the ACAAI Annual Scientific Meeting to life each year? Believe it or not, planning takes years to prepare.
2024 Cyberattacks cause disruptions
Due to the attack, Change Healthcare's systems are still down, causing struggles for physician practices and hospitals filing claims, as well as for pharmacies…
AllergyTalk: Two Special Podcasts: Omalizumab for Food Allergy
On February 16, 2024, the FDA announced the approval of the first biologic medication to treat patients with food allergy, omalizumab
Clinical Trial Resources provide an important link to medical research
Learn about opportunities that may help your patients either now or in the future.
Addressing Cannabis use with patients
A survey revealed 75% of surveyed allergists were only somewhat knowledgeable about respiratory effects and allergic reactions to cannabis